Following Push & Questioning From Sen. Hassan, FDA Announces It Has Stopped Issuing Contracts to McKinsey Pending Federal Investigations
April 27, 2022
April 27, 2022
WASHINGTON, April 27 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
Following questioning from U.S. Senator Maggie Hassan (D-NH), a top official at the Food and Drug Administration (FDA) announced that the FDA has stopped issuing contracts to the consulting firm, McKinsey & Co., while ongoing investigations look into the failure by McKinsey to disclose potential conflicts of interest while the firm was working with the FDA on issues related to opioids . . .
Following questioning from U.S. Senator Maggie Hassan (D-NH), a top official at the Food and Drug Administration (FDA) announced that the FDA has stopped issuing contracts to the consulting firm, McKinsey & Co., while ongoing investigations look into the failure by McKinsey to disclose potential conflicts of interest while the firm was working with the FDA on issues related to opioids . . .